Sarepta Therapeutics: Q4 Earnings Snapshot
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Wednesday reported fourth-quarter net income of $45.7 million.
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Sarepta Therapeutics Inc. (SRPT) on Wednesday reported fourth-quarter net income of $45.7 million.
Suggested Reading
On a per-share basis, the Cambridge, Massachusetts-based company said it had net income of 47 cents.
Related Content
The results exceeded Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 3 cents per share.
The biopharmaceutical company posted revenue of $396.8 million in the period, which also topped Street forecasts. Nine analysts surveyed by Zacks expected $382.1 million.
For the year, the company reported a loss of $536 million, or $5.80 per share. Revenue was reported as $1.24 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SRPT at https://www.zacks.com/ap/SRPT